Dermatan Sulfate Concept

Vocabulary Service

MeSH

Overview

subject area of

A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep Academic Article
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Academic Article
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Academic Article
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II Academic Article
Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes Academic Article
Current agents for the treatment of patients with heparin-induced thrombocytopenia Academic Article
DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE Academic Article
Dermatan sulphate in heparin-induced thrombocytopenia Academic Article
Effect of Covalent Serpin–Heparinoid Complexes on Plasma Thrombin Generation on Fetal Distal Lung Epithelium Academic Article
Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents Academic Article
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo Academic Article
Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli Academic Article
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits Academic Article
Evidence for thrombin binding to dermatan sulphate sites in the rabbit aorta subendothelium in vitro Academic Article
Extraction and analysis of glycosaminoglycans from intima-media of single rabbit aortae: effect of balloon catheter de-endothelialization on the content and profile of glycosaminoglycans Academic Article
Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Academic Article
Glycosaminoglycans Bind Factor Xa in a Ca²⁺-Dependent Fashion and Modulate Its Catalytic Activity Academic Article
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Academic Article
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Academic Article
Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Academic Article
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Academic Article
Heparin-induced thrombocytopenia and its treatment. Conference Paper
Heparin-induced thrombocytopenia in intensive care patients Academic Article
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Academic Article
Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS Academic Article
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Academic Article
In vivo activity of a new heparinoid. Academic Article
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis Academic Article
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Academic Article
Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma Academic Article
Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice Academic Article
Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition Academic Article
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
Low molecular weight heparins and heparinoids Academic Article
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Academic Article
Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides Academic Article
Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Academic Article
Modulation of the Enzymatic Activity of α-Thrombin by Polyanions: Consequences on Intrinsic Activation of Factor V and Factor VIII Academic Article
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin Academic Article
Molecular Mapping of the Thrombin-Heparin Cofactor II Complex Academic Article
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients Academic Article
Parenteral Anticoagulants Academic Article
Parenteral Anticoagulants Academic Article
Pharmacological Actions of Sulodexide Academic Article
Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfate Academic Article
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium. Academic Article
Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Academic Article
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides Academic Article
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s Academic Article
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Academic Article
The haemorrhagic and antithrombotic effects of dermatan sulphate. Academic Article
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Academic Article
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Academic Article
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa Academic Article
Vasoflux, a New Anticoagulant With a Novel Mechanism of Action Academic Article
Venous thromboembolism in heparin-induced thrombocytopenia Academic Article